Published: 17 March 2020
Author(s): Michela Giustozzi, Maurizio Paciaroni
Issue: March 2020
Section: Commentary

Embolic stroke of undetermined source (ESUS) accounts for up of 25% of all ischaemic strokes and its risk of recurrence has been estimated to be approximately 5% per year [1,2]. The concept of ESUS was proposed in 2014 to classify a subset of ischaemic stroke with no identifiable causes of embolism despite a structured diagnostic work-up [3]. As the most accepted concept of the ESUS retains that most cryptogenic strokes may be thromboembolic, these would likely benefit from anticoagulant therapy.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.